Innovative pharmaceutical concept stocks are active again, New Bai in Nanjing hits limit up for two consecutive days.

Innovative drug concept stocks are repeatedly active, with Nanjing Xinbai up two limit boards, BeiGene's growth exceeding 6%, and Sea Horizon Pharmaceutical, Linkhealth Technology, Wanze shares, and Xintai following the increase.